Boston Scientific to buy neuromodulation company Axonics for $3.7bn
Axonics is a medical technology company primarily focused on the development and marketing of sacral neuromodulation (SNM) therapies…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Jan 24
Axonics is a medical technology company primarily focused on the development and marketing of sacral neuromodulation (SNM) therapies…
04 Jan 24
Proceeds will accelerate commercial growth and expand clinical and health-economic evidence for the innovative Nalu neurostimulation system featuring…
15 Dec 23
The first three enrolled patients received scheduled stent-assisted coiling procedures and were treated successfully at Hyogo, Japan-based Kobe…
13 Dec 23
The Hippo catheter's proprietary adaptive tip is designed to ensure precision in engaging and removing clots, thereby delivering…
12 Dec 23
First FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the…
08 Dec 23
Available now, this brand new Neurological Keyboard allows typing by thought, instantly and without any brain surgery
21 Nov 23
Pixyl.Neuro automatically analyses brain MRI images to support rapid detection, early diagnosis and objective monitoring of neurological disorders,…
17 Nov 23
The NASDAQ-listed, commercial-stage and AI-driven combined company will focus on the development and commercialisation of Firefly’s BNA platform…
17 Nov 23
ManaFlexx 2 was previously indicated for Neuromuscular Electrical Stimulation (NMES) and Transcutaneous Electrical Nerve Stimulation (TENS), as a…
15 Nov 23
Vy Spine’s proprietary OsteoVy lattice structure aids in bony integration as well as wicking, PEKK being a hydrophilic…